Pages that link to "Q28368336"
Jump to navigation
Jump to search
The following pages link to The M539V Polymerase Variant of Human Hepatitis B Virus Demonstrates Resistance to 2′-Deoxy-3′-Thiacytidine and a Reduced Ability to Synthesize Viral DNA (Q28368336):
Displaying 13 items.
- Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine (Q24519050) (← links)
- Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus (Q28365198) (← links)
- Development of resistance and perspectives for future therapies against hepatitis B infections: lessons to be learned from HIV. (Q33961795) (← links)
- Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine (Q33963063) (← links)
- Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B. (Q34648598) (← links)
- Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening (Q35014297) (← links)
- Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication (Q39277056) (← links)
- Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy (Q39455322) (← links)
- Kinetic analysis of wild-type and YMDD mutant hepatitis B virus polymerases and effects of deoxyribonucleotide concentrations on polymerase activity (Q39651471) (← links)
- Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro (Q39652624) (← links)
- Emergence of a novel mutation in the FLLA region of hepatitis B virus during lamivudine therapy (Q40404519) (← links)
- Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities (Q41091378) (← links)
- Molecular, immunological and clinical properties of mutated hepatitis B viruses. (Q43988430) (← links)